<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01904617</url>
  </required_header>
  <id_info>
    <org_study_id>025-11</org_study_id>
    <nct_id>NCT01904617</nct_id>
  </id_info>
  <brief_title>Effects of Rate and/or Presence of Dextrose on the Labor Course of Nulliparas</brief_title>
  <official_title>A Randomized Controlled Trial on the Effects of Rate and/or Presence of Dextrose on the Labor Course of Nulliparas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MemorialCare Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MemorialCare Health System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized controlled trial aims to compare three groups of intravenous fluids and their&#xD;
      impact on labor: 1) 125 mL/hr of 5% dextrose in normal saline 2) 250 mL/hr of normal saline&#xD;
      3) 250 mL/hr of 5% dextrose in normal saline&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Currently, patients who arrive to labor and delivery automatically receive IV fluid hydration&#xD;
      as part of a standard order set. The current default IV fluid order is 125mL/hr of 5%&#xD;
      dextrose, either in normal saline or lactated ringers.&#xD;
&#xD;
      Any patient delivering for the first time presenting to labor and delivery in active labor&#xD;
      will be screened. If they meet inclusion requirements they will be offered enrollment.&#xD;
&#xD;
      Subjects will be blindly randomized to receive one of three different types of IV fluids:&#xD;
&#xD;
        1. 5% dextrose Normal saline (Normal saline plus 5g/dl of glucose) at 125 mL/hr (the&#xD;
           current LBMMC default inpatient IV order set)&#xD;
&#xD;
        2. Normal saline (a solution containing sodium and chloride) at 250 mL/hr&#xD;
&#xD;
        3. 2.5% dextrose Normal saline at 125 mL/hr&#xD;
&#xD;
             -  Management of labor will be at the discretion of the attending physician(s).&#xD;
&#xD;
             -  Maternal outcomes to be measured include: 1) total amount of IV fluids&#xD;
                administered, 2) length of labor, 3) epidural use, 4) oxytocin use, 5) mode of&#xD;
                delivery, 6) development of maternal infections or other morbidity such as&#xD;
                postpartum hemorrhage.&#xD;
&#xD;
             -  Neonatal outcomes to be measured include: 1) birth weight, 2) Apgar scores, 3)&#xD;
                hospital course (nursery placement and length of stay), 4) need for treatment of&#xD;
                jaundice.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">April 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Length of labor</measure>
    <time_frame>Time from fluid initiation to delivery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time of second stage of labor</measure>
    <time_frame>Time from initiation of pushing to delivery</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Length of Labor</condition>
  <condition>Second Stage of Labor</condition>
  <condition>Intravenous Hydration of Labor</condition>
  <arm_group>
    <arm_group_label>D5NS at 125 mL/hr</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5% dextrose in normal saline at 125 mL/hr</description>
  </arm_group>
  <arm_group>
    <arm_group_label>D2.5NS at 250mL/hr</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2.5% dextrose in normal saline at 250 mL/hr</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NS at 250mL/hr</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Normal saline at 250mL/hr</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dextrose</intervention_name>
    <arm_group_label>D2.5NS at 250mL/hr</arm_group_label>
    <arm_group_label>D5NS at 125 mL/hr</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Normal Saline</intervention_name>
    <arm_group_label>D2.5NS at 250mL/hr</arm_group_label>
    <arm_group_label>D5NS at 125 mL/hr</arm_group_label>
    <arm_group_label>NS at 250mL/hr</arm_group_label>
    <other_name>Intravenous fluids, normal saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  • Primiparous&#xD;
&#xD;
               -  Singleton gestation&#xD;
&#xD;
               -  Vertex presentation&#xD;
&#xD;
               -  Spontaneous active labor with or without pitocin augmentation&#xD;
&#xD;
               -  Gestational age &gt; 36 weeks&#xD;
&#xD;
               -  Cervical dilation 3 to 5 cm with or without ruptured membranes&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  • Multiparous&#xD;
&#xD;
               -  Pregestational or gestational diabetes mellitus&#xD;
&#xD;
               -  Preeclampsia at admission&#xD;
&#xD;
               -  Previous cesarean section&#xD;
&#xD;
               -  Non-vertex presentation&#xD;
&#xD;
               -  Multiple gestation&#xD;
&#xD;
               -  Chorioamnionitis at admission&#xD;
&#xD;
               -  Intrauterine growth restriction (&lt; 10th percentile)&#xD;
&#xD;
               -  Patients admitted for induction&#xD;
&#xD;
               -  BMI &gt; 50&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vineet Shrivastava, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Long Beach Memorial Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Long Beach Memorial Medical Center</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2015</verification_date>
  <study_first_submitted>April 19, 2013</study_first_submitted>
  <study_first_submitted_qc>July 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2013</study_first_posted>
  <last_update_submitted>January 7, 2015</last_update_submitted>
  <last_update_submitted_qc>January 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Length of labor</keyword>
  <keyword>second stage of labor</keyword>
  <keyword>intravenous hydration of labor</keyword>
  <keyword>intravenous glucose</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

